anti-SARS antibodies (Verenium)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-SARS antibodies (Verenium)
Drug Alias Name61G4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVerenium Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVerenium Corp
Active IndicationsN/A
Inactive IndicationsSevere Acute Respiratory Syndrome

Other Information

ATC CodeN/A
Related LinksN/A